ArticleCancers2021

A Nomogram-Based Prognostic Model for Advanced Hepatocellular Carcinoma Patients Treated with Sorafenib: A Multicenter Study.

Giovanni Marasco et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.